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ABSTRACT 
Objective: To report a simple and economic alternative spectrophotometric micro-method for the determination of acetaminophen using 200 µl of 
plasma sample. 
Methods: The analyses were based on a simple colorimetric test in which p-aminophenol, after an acidic hydrolysis step, is reacted with phenol in 
an alkaline medium to form an indophenol dye which exhibits a maximum extintion at 625 nm. The micro method was validated according to the 
international criteria, and then it was used for the quantification of plasma levels of acetaminophen after rectal administration of 100 mg of the drug 
to male New Zealand rabbits.  
Results: The analytical recovery was 100.97%, with solutions of 5−25 µg/ml (plasma/water). The linearity with plasma solutions was good (R2 = 
0.995), at the same concentration levels. The within-run and between-run precision, as well as accuracy expressed as coefficient of variation, were 
less than 8%. The mean accuracy was 102.24%. The stability was proved for a one-week period at −20 °C. The pharmacokinetic parameters were 
computed by non-linear regression analysis. The non-compartment model analysis was used to fit the in vivo data. 
Conclusion: The validation parameters were within acceptable limits for clinical studies. The analysis was adequate for the determination of 
acetaminophen in small plasma samples, and it can be easily adapted by any hospital or clinical laboratory with non-special equipment. 
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Acetaminophen (N-acetyl-p-aminophenol) is widely used in 
antipyretic and analgesic therapy. This compound is generally 
perceived to be a safe agent, but chronic abuse or acute overdose can 
lead to hepatotoxicity [1]. The analytical methods to monitor 
acetaminophen are especially important in the neonatal and 
paediatric population, or in small animals where samples are often 
difficult to obtain, and the blood volume is limited. An easy way to 
quantify acetaminophen is based on a simple colorimetric test in 
which p-aminophenol, after an acidic hydrolysis step, is reacted with 
phenol in an alkaline medium to form an indophenol dye [2, 3]. Some 
of the published colorimetric methods utilize more than 0.5 ml of 
plasma or serum sample [3-6] so, laboratories that use analytical 
methods with limited plasma samples, could successfully perform 
the quantification of acetaminophen in paediatric population or in 
small laboratory animals. In this case, the sample volume should be 
as small as possible without causing damage to children, as a 
repeated blood sampling has been associated with neonatal anemia 
[7]. Previous researchers have reported, the spectrophotometric 
determination of some antihypertensive drugs in biological fluids 
using sulphonphthalein dyes [8], and the traces amount of 
acetaminophen in human plasma [9]. Our aim was to present an 
alternative micro method based on the indophenol reaction for the 
detection of acetaminophen in 200 µl of plasma sample. It provides a 
simple and economical screening test to be used in the laboratory. The 
method was applied to the determination of acetaminophen in plasma 
samples arising from a pharmacokinetic study in rabbits. This animal 
model has been used for pharmacokinetic studies of antipsychotic 
agent [10]. In our work, New Zealand rabbits were employed, and 
plasma levels of acetaminophen were determined after administration 
of a rectal solution with the therapeutic dose of 100 mg of the drug. 
Acetaminophen was purchased from Sigma-Aldrich Co. (St Louis, 
MO, USA). Methanol, 25% liquid NH3, concentrated HCl, 
trichloroacetic acid, and phenol were analytical grade supplied by 
Merck-Mexico SA (Naucalpan, Mexico). The spectrophotometric 
apparatus was a Perkin Elmer UV/Vis Spectrometer Lambda 2S 
(Norwalk, CT, USA). The stock solution of acetaminophen (1 mg/ml) 
was prepared in methanol, and it was stored at 4 °C until use. 
Appropriate dilutions of acetaminophen were made in drug-free 
plasma to give final concentrations of 5, 10, 15, 20, and 25 µg/ml. 
The concentration range of 10−20 µg/ml corresponds to commonly 
associated levels with antipyresis, after a single rectal dose of 25 
mg/kg [11, 12]. The procedure was adapted and validated from that 
reported by Frings and Saloom [3]. The determination consists in 
the reaction between p-aminophenol and phenol, in an alkaline 
medium to form an indophenol dye, which exhibits a maximum 
extinction at 625 nm. The p-aminophenol is the hydrolysis product 
of acetaminophen and its metabolites, so by this way the total drug 
is quantified. Briefly, to an aliquot of heparinized plasma (200 µl of 
standard or sample), 200 µl of 20% trichloroacetic acid was added. 
The high concentration of trichloroacetic acid was necessary to 
produce a solid precipitation of the plasma proteins. The 
constituents then were vortexed for 10 s, and centrifuged at 5000 
rpm for 10 min. The supernatant was recovered, and 100 µl of 
concentrated HCl was added. After vortexed again for 5 s, the 
constituents were placed 35 min in a boiling water bath for hydrolysis, 
then 500 µl of liquid NH3, and 400 µl of 4% phenol were added. Finally, 
after 30 min acetaminophen was determined at 625 nm. 
The absolute recovery of acetaminophen from plasma was 
determined to analyze three standard calibration curves in plasma, 
and three standard curves in water. The absorbances of 
acetaminophen in plasma were related with the absorbances of 
acetaminophen in water by simple linear regression analysis. To 
evaluate linearity, the standards calibration curves were prepared 
by plotting absorbance vs. concentrations of acetaminophen in 
plasma. The slopes were determined using a linear least-square 
regression analysis. All results are expressed as mean±standard 
deviation (SD). The within-run precision of the assay was 
determined by the analysis of five plasma solutions, with different 
acetaminophen concentrations, by replicate (n = 3). The between-
run precision of the method was evaluated by performing six 
standard curves in plasma using three different concentrations (low, 
medium, and high), over a range of 5−25 µg/ml. The between-run 
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precision was investigated during a four-week period [13, 14]. The 
accuracy of the method was determined in plasma samples, 
containing acetaminophen with 5−25 µg/ml, prepares by one person 
and assessed by another who had no knowledge of the 
concentrations. The samples were analyzed with respect to a 
standard calibration curve in plasma. The mean accuracy, 95% 
confidence limits (CI95%), and its coefficient of variation (CV) were 
calculated. The analytical results were also compared in a graph, in 
which the determined vs. known concentrations were plotted. To 
test stability, the spiked blank plasma samples at three different 
concentrations (low, medium, and high) were made and they were 
analyzed at the one-week period, after storing at −20 °C performing 
replicates (n = 3). The plasma concentrations of drug were 
determined with reference to a standard calibration curve, obtained 
by plotting the absorbances vs. known plasma concentrations of 
acetaminophen, prepared the same day of the analysis [13, 14]. The 
method was applied in a pharmacokinetic study in rabbits. The 
animals were treated according to a protocol approved by the local 
Animal Ethics Committee (CICUAL. UAM-X.29), and following the 
Mexican federal regulations for the care and use of laboratory 
animals NOM-062-ZOO-1999 [15]. Six white male New Zealand 
rabbits (weight 3−4 kg) were used as an animal model. The animals 
fasted 12 h before the test. Before rectal administration, a 500 µl of 
blood sample was withdrawn from the marginal vein of each animal 
to serve as a control. At zero time, rabbits were treated with an 
aqueous solution of acetaminophen in a single dose of 100 mg. After 
administration, 500 µl of blood samples were taken at 0.25, 0.5, 1.0, 
1.5, and 2 h and they were collected in heparinized polypropylene 
tubes. The plasma was separated by centrifugation and immediately 
frozen until their test according to the method described above. The 
pharmacokinetic parameters were computed by non-linear regression 
analysis using the WinNonlin version 2.1 (Parsight Corp. Palo Alto, CA, 
USA). The non-compartment model analysis was used to fit the in vivo 
data. Data are given as mean±standard error of the mean (SEM). 
The analytical recovery was performed relating the absorbances of 
acetaminophen in plasma solutions, with respect to the absorbances 
of acetaminophen in water solutions, over a concentration range of 
5−25 µg/ml. The slope of the regression line showed an average 
analytical recovery of 100.97%, with 90.34−111.59% as CI95%. Three 
standard calibration curves of acetaminophen in plasma were made 
at different times over a two-week period. The mean slope of the 
absorbances vs. acetaminophen concentrations was 0.0133±0.001 
(CV = 2.4%, and R2 = 0.995). The corresponding intercept was 
−0.043±0.014. The value of the intercept was not significantly 
different from zero, in any of the three standard calibration curves 
(*P>0.05). The CV calculated to prove the within-run precision of the 
test, in five plasma solutions, was 0.74−2.89%. The between-run 
precision was calculated from the slopes of six standards calibration 
curves, which were independently prepared. The CV of the slopes 
was 6.91%. The mean accuracy of the method was 102.24%, with 
94.67−109.53% as CI95%, and CV of 7.77%. When the determined vs. 
known acetaminophen concentrations were plotted, the regression 
equation was: y = 1.0211x − 0.101, and R2 = 0.994. The values of the 
slope and intercept do not significantly differ from 1 and 0, 
respectively (*P>0.05). No significant differences were found in 
samples stored at −20 °C during a one-week period (*P>0.05). The 
time of stability test was adequate because in an emergency case, the 
plasma samples will be analyzed as soon as possible, and is not 
necessary to store the plasma samples for a long period of time. 
By the acceptable precision and accuracy of the method, it was 
successfully used in a pharmacokinetic study with rabbits. A typical 
plasma concentration-time profile of acetaminophen, obtained after 
rectal administration of an aqueous solution, in a single dose of 100 
mg/rabbit is illustrated in fig. 1. Additionally, the mean 
pharmacokinetic parameters calculated with non-compartment 
model analysis are shown in table 1. A moderate inter-individual 
variability was observed in the kinetic parameters.  
 
 
Fig. 1: Plasma concentration-time profile of acetaminophen 
(100 mg) following rectal administration of an aqueous 
solution to male New Zealand rabbits. mean±SEM, n = 6
 
Table 1: Pharmacokinetic parameters calculated with non-compartment model analysis after rectal administration of acetaminophen 
(100 mg) to rabbits 
Parameter Value Parameter Value 
Cmax (µg/ml) 39.24±6.05 MRT (h) 0.95±0.03 
Tmax (h) 0.71±0.14 λz (h-1) 0.64±0.08 
AUC0→t (µgh/ml) 55.78±9.81 t½ (h) 1.21±0.20 
AUC: area under the curve, MRT: mean residence time. mean±SEM, n = 6 
 
Some pharmacokinetic parameters calculated in this work agree 
with those reported by other researchers, e. g. the Cmax value of 
39.24±6.05 µg/ml with the Cmax value of 25 µg/ml, found after rectal 
administration of a commercial suppository with 100 mg of 
acetaminophen to rabbits [16]. Although it is the same dose used by 
us, our data is slightly higher due to acetaminophen was 
administered in an aqueous solution. 
The colorimetric method described in this paper allows the quantitative 
determination of acetaminophen in plasma samples of 200 µl. The 
method is simple and economic. The validation parameters evaluated in 
this work were within acceptable limits for clinical studies. The method 
was applied to the analysis of plasma samples obtained from a 
pharmacokinetic study in rabbits. The test is suitable for monitor the 
plasma levels of acetaminophen, and it can be easily adapted by any 
hospital or clinical laboratory with non-special equipment. 
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